| Temasek Holdings (Pvt.) Ltd, an investment firm based in Singapore, has invested more than $600 million to buy stakes in three Indian drug makers over the past six months, raising its bets on the Indian pharmaceutical industry that has given investors among the highest returns over the past few years.
Two of these deals were in publicly traded firms—Sun Pharmaceutical Industries Ltd and Glenmark Pharmaceuticals Ltd. The third investment was in Intas Pharmaceuticals Ltd. The three transactions were ranked among the top five private equity (PE) deals in the pharmaceutical sector over the last five years, according to data from researcher VCCEdge...............................................Full Article: Source
|